Ailawadhi, Sikander https://orcid.org/0000-0002-8377-8111
Lee, Hans C. https://orcid.org/0000-0001-8545-3292
Omel, James
Toomey, Kathleen
Hardin, James W.
Gasparetto, Cristina J.
Jagannath, Sundar https://orcid.org/0000-0003-2934-6518
Rifkin, Robert M. https://orcid.org/0000-0003-3141-1518
Durie, Brian G. M.
Narang, Mohit
Terebelo, Howard R.
Joshi, Prashant
Jou, Ying-Ming
Mouro, Jorge
Yu, Edward
Abonour, Rafat
Funding for this research was provided by:
Bristol-Myers Squibb Company | Bristol-Myers Squibb Canada
Article History
Received: 13 June 2024
Revised: 27 September 2024
Accepted: 21 October 2024
First Online: 11 November 2024
Competing interests
: Sikander Ailawadhi reports serving on a scientific steering committee for Bristol Myers Squibb; consulting fees from BeiGene, Bristol Myers Squibb, Cellectar, GSK, Janssen, Pfizer, Regeneron, Sanofi, and Takeda; and research funding from AbbVie, Amgen, Ascentage, Bristol Myers Squibb, Cellectar, GSK, Janssen, Pharmacyclics, and Sanofi. Hans C. Lee reports serving on a scientific steering committee for Bristol Myers Squibb; consulting fees from Allogene, Bristol Myers Squibb, Genentech, GSK, Janssen, Monte Rosa Therapeutics, Pfizer, Regeneron, Sanofi, and Takeda; and grants or contracts from Amgen, Bristol Myers Squibb, GSK, Janssen, Regeneron, and Takeda. James Omel, Kathleen Toomey, James W. Hardin, Brian G.M. Durie, Mohit Narang, Howard R. Terebelo, and Rafat Abonour report serving on a scientific steering committee for Bristol Myers Squibb. Cristina J. Gasparetto reports serving on a scientific steering committee for Bristol Myers Squibb; support for travel from Bristol Myers Squibb, Karyopharm, and Sanofi; advisory role for Bristol Myers Squibb, Janssen, and Pfizer; and for Bristol Myers Squibb, Karyopharm, and Sanofi. Sundar Jagannath reports serving on a scientific steering committee for Bristol Myers Squibb; consulting fees from Bristol Myers Squibb, Janssen, Karyopharm Therapeutics, Legend Biotech, Regeneron Sanofi, and Takeda; support for travel from American Society of Clinical Oncology, American Society of Hematology (ASH), and International Myeloma Society (IMS); participation on data safety monitoring boards for Bristol Myers Squibb, Janssen, and Sanofi; and leadership or fiduciary role for ASH, IMS, and Society of Hematologic Oncology. Robert M. Rifkin reports serving on a scientific steering committee for Bristol Myers Squibb; employment, stock, and other ownership interests with McKesson; participation on data safety monitoring board for CARsgen; and advisory role with Amgen, Bristol Myers Squibb; Coherus BioSciences, Genmab, Fresenius Kabi, and Janssen. Ying-Ming Jou reports employment and stock and other ownership interests with Bristol Myers Squibb. Prashant Joshi, Jorge Mouro, and Edward Yu are former employees of Bristol Myers Squibb.